Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12186697 | 1.00 | KDM4E (0.41) | KDM4EHSD17B10MAPK1ALDH1A1TDP1 | |
| SCHEMBL17425138 | 0.86 | — | — | |
| SCHEMBL5864350 | 0.86 | — | — | |
| SCHEMBL19951536 | 0.86 | — | — | |
| SCHEMBL2136195 | 0.86 | MAPK1 (0.38) | KDM4EHSD17B10MAPK1ALDH1A1TDP1 | |
| SCHEMBL2141114 | 0.86 | MAPK1 (0.38) | KDM4EHSD17B10MAPK1ALDH1A1TDP1 | |
| SCHEMBL1251577 | 0.86 | CYP1A2 (0.33) | KDM4EHSD17B10TDP1CYP1A2 | |
| SCHEMBL2138060 | 0.84 | MAPK1 (0.37) | KDM4EHSD17B10MAPK1ALDH1A1TDP1 | |
| SCHEMBL11075927 | 0.84 | MAPK1 (0.37) | KDM4EHSD17B10MAPK1ALDH1A1TDP1 | |
| SCHEMBL5864348 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | THE PROCTER & GAMBLE COMPANY (US) | 2025-02-25 | — | — | US | claimed |
| US-20250051370-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2025-02-13 | — | — | US | claimed |
| US-20220064191-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2022-03-03 | — | — | US | claimed |
| EP-3218425-B1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2020-05-13 | — | — | EP | claimed |
| US-20170327647-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2017-11-16 | — | — | US | claimed |
| WO-2017196762-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-16 | — | — | WO | claimed |
| EP-3218425-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2017-09-20 | — | — | EP | claimed |
| US-20160137674-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2016-05-19 | — | — | US | claimed |
| WO-2016077513-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2016-05-19 | — | — | WO | claimed |
| US-20070037733-A1 | Use of 3-cyclohexenyl-1-propanol as a fragrance | SYMRISE GMBH & CO. KG (DE) | 2007-02-15 | — | — | US | claimed |
| US-7097890-B1 | Polymer with pendent cyclic olefinic functions for oxygen scavenging packaging | CHEVRON PHILLIPS CHEMICAL CO. LP (US) | 2006-08-29 | — | — | US | claimed |
| EP-1670420-A1 | USE OF 3-CYCLOHEXENYL-1-PROPANOL AS A PERFUME | Symrise GmbH & Co. KG (DE) | 2006-06-21 | — | — | EP | claimed |
| WO-2005030156-A1 | USE OF 3-CYCLOHEXENYL-1-PROPANOL AS A PERFUME | SYMRISE GMBH & CO. KG (DE) | 2005-04-07 | — | — | WO | claimed |
| EP-1066337-B1 | OXYGEN SCAVENGERS WITH REDUCED OXIDATION PRODUCTS FOR USE IN PLASTIC FILMS AND BEVERAGE AND FOOD CONTAINERS | CHEVRON PHILLIPS CHEMICAL CO (US) | 2004-11-03 | — | — | EP | claimed |
| EP-1066337-A2 | OXYGEN SCAVENGERS WITH REDUCED OXIDATION PRODUCTS FOR USE IN PLASTIC FILMS AND BEVERAGE AND FOOD CONTAINERS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2001-01-10 | — | — | EP | claimed |
| WO-1999048963-A2 | OXYGEN SCAVENGERS WITH REDUCED OXIDATION PRODUCTS FOR USE IN PLASTIC FILMS AND BEVERAGE AND FOOD CONTAINERS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 1999-09-30 | — | — | WO | claimed |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | THE PROCTER & GAMBLE COMPANY (US) | 2025-02-25 | — | — | US | disclosed |
| US-20250051370-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2025-02-13 | — | — | US | disclosed |
| EP-1066337-A2 | OXYGEN SCAVENGERS WITH REDUCED OXIDATION PRODUCTS FOR USE IN PLASTIC FILMS AND BEVERAGE AND FOOD CONTAINERS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2001-01-10 | — | — | EP | disclosed |
| WO-1999048963-A2 | OXYGEN SCAVENGERS WITH REDUCED OXIDATION PRODUCTS FOR USE IN PLASTIC FILMS AND BEVERAGE AND FOOD CONTAINERS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 1999-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137674-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | KDM4E 875/4885HSD17B10 948/4885MAPK1 4178/4885 |
| US-20250051370-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | KDM4E 875/4885HSD17B10 948/4885MAPK1 4178/4885 |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | SMS, SRM, AAAS | KDM4E 321/4885HSD17B10 2759/4885MAPK1 4194/4885 |
| US-20220064191-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | KDM4E 875/4885HSD17B10 948/4885MAPK1 4178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.